ONEST in Breast Cancer and Its Limitations
Tumour-infiltrating lymphocytes (TILs) reflect the host's response against tumours. TILs have a strong prognostic effect in the so-called triple-negative (oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 negative) subset of breast cancers and predict a bet...
Gespeichert in:
Veröffentlicht in: | Cancers 2023-02, Vol.15 (4) |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 4 |
container_start_page | |
container_title | Cancers |
container_volume | 15 |
creator | Cserni, Bálint Kilma O’Loughlin, Mark Andreu, Xavier Bagó-Horváth, Zsuzsanna Bianchi, Simonetta Chmielik, Ewa Figueiredo, Paulo Floris, Giuseppe Foschini, Maria Pia Kovács, Anikó Heikkilä, Päivi Kulka, Janina Laenkholm, Anne-Vibeke Liepniece-Karele, Inta Marchiò, Caterina Provenzano, Elena Regitnig, Peter Reiner, Angelika Ryška, Aleš Sapino, Anna Stovgaard, Elisabeth Specht Quinn, Cecily Zolota, Vasiliki Webber, Mark Glynn, Sharon A Bori, Rita Csörgő, Erika Oláh-Németh, Orsolya Pancsa, Tamás Sejben, Anita Sejben, István Vörös, András Zombori, Tamás Nyári, Tibor Callagy, Grace Cserni, Gábor |
description | Tumour-infiltrating lymphocytes (TILs) reflect the host's response against tumours. TILs have a strong prognostic effect in the so-called triple-negative (oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 negative) subset of breast cancers and predict a better response when primary systemic (neoadjuvant) treatment is administered. Although they are easy to assess, their quantitative assessment is subject to some inter-observer variation. ONEST (Observers Needed to Evaluate Subjective Tests) is a new way of analysing inter-observer variability and helps in estimating the number of observers required for a more reliable estimation of this phenomenon. This aspect of reproducibility for TILs has not been explored previously. Our analysis suggests that between six and nine pathologists can give a good approximation of inter-observer agreement in TIL assessments. Tumour-infiltrating lymphocytes (TILs) reflect antitumour immunity. Their evaluation of histopathology specimens is influenced by several factors and is subject to issues of reproducibility. ONEST (Observers Needed to Evaluate Subjective Tests) helps in determining the number of observers that would be sufficient for the reliable estimation of inter-observer agreement of TIL categorisation. This has not been explored previously in relation to TILs. ONEST analyses, using an open-source software developed by the first author, were performed on TIL quantification in breast cancers taken from two previous studies. These were one reproducibility study involving 49 breast cancers, 23 in the first circulation and 14 pathologists in the second circulation, and one study involving 100 cases and 9 pathologists. In addition to the estimates of the number of observers required, other factors influencing the results of ONEST were examined. The analyses reveal that between six and nine observers (range 2-11) are most commonly needed to give a robust estimate of reproducibility. In addition, the number and experience of observers, the distribution of values around or away from the extremes, and outliers in the classification also influence the results. Due to the simplicity and the potentially relevant information it may give, we propose ONEST to be a part of new reproducibility analyses. |
doi_str_mv | 10.3390/cancers15041199 |
format | Article |
fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A743010315</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A743010315</galeid><sourcerecordid>A743010315</sourcerecordid><originalsourceid>FETCH-LOGICAL-g675-1f16aa1bb65c0839e8a6ef9930c478592b3ab2561b28041ab1169cefd05644fd3</originalsourceid><addsrcrecordid>eNptjr1rwzAQxUVpoCHN3FXQreBUZ31ZY2rSNGCaId7DSZaCSiyD5f-fmrZDht4N73G89-MIeQK24dywV4fJ-TGDZALAmDuyLJkuC6WMuL_xD2Sd8xebh3PQSi_Jy_Fzd2ppTPRt9JgnWv-QKKaOHqZMm9jHCac4pPxIFgGv2a__dEXa911bfxTNcX-ot01xUVoWEEAhgrVKOlZx4ytUPhjDmRO6kqa0HG0pFdiymp9FC6CM86FjUgkROr4iz7_YC179OaYwTCO6PmZ33mrBGTAOck5t_knN2_k-uiH5EOf7TeEbY3dSUw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>ONEST in Breast Cancer and Its Limitations</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>PubMed Central</source><creator>Cserni, Bálint ; Kilma ; O’Loughlin, Mark ; Andreu, Xavier ; Bagó-Horváth, Zsuzsanna ; Bianchi, Simonetta ; Chmielik, Ewa ; Figueiredo, Paulo ; Floris, Giuseppe ; Foschini, Maria Pia ; Kovács, Anikó ; Heikkilä, Päivi ; Kulka, Janina ; Laenkholm, Anne-Vibeke ; Liepniece-Karele, Inta ; Marchiò, Caterina ; Provenzano, Elena ; Regitnig, Peter ; Reiner, Angelika ; Ryška, Aleš ; Sapino, Anna ; Stovgaard, Elisabeth Specht ; Quinn, Cecily ; Zolota, Vasiliki ; Webber, Mark ; Glynn, Sharon A ; Bori, Rita ; Csörgő, Erika ; Oláh-Németh, Orsolya ; Pancsa, Tamás ; Sejben, Anita ; Sejben, István ; Vörös, András ; Zombori, Tamás ; Nyári, Tibor ; Callagy, Grace ; Cserni, Gábor</creator><creatorcontrib>Cserni, Bálint ; Kilma ; O’Loughlin, Mark ; Andreu, Xavier ; Bagó-Horváth, Zsuzsanna ; Bianchi, Simonetta ; Chmielik, Ewa ; Figueiredo, Paulo ; Floris, Giuseppe ; Foschini, Maria Pia ; Kovács, Anikó ; Heikkilä, Päivi ; Kulka, Janina ; Laenkholm, Anne-Vibeke ; Liepniece-Karele, Inta ; Marchiò, Caterina ; Provenzano, Elena ; Regitnig, Peter ; Reiner, Angelika ; Ryška, Aleš ; Sapino, Anna ; Stovgaard, Elisabeth Specht ; Quinn, Cecily ; Zolota, Vasiliki ; Webber, Mark ; Glynn, Sharon A ; Bori, Rita ; Csörgő, Erika ; Oláh-Németh, Orsolya ; Pancsa, Tamás ; Sejben, Anita ; Sejben, István ; Vörös, András ; Zombori, Tamás ; Nyári, Tibor ; Callagy, Grace ; Cserni, Gábor</creatorcontrib><description>Tumour-infiltrating lymphocytes (TILs) reflect the host's response against tumours. TILs have a strong prognostic effect in the so-called triple-negative (oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 negative) subset of breast cancers and predict a better response when primary systemic (neoadjuvant) treatment is administered. Although they are easy to assess, their quantitative assessment is subject to some inter-observer variation. ONEST (Observers Needed to Evaluate Subjective Tests) is a new way of analysing inter-observer variability and helps in estimating the number of observers required for a more reliable estimation of this phenomenon. This aspect of reproducibility for TILs has not been explored previously. Our analysis suggests that between six and nine pathologists can give a good approximation of inter-observer agreement in TIL assessments. Tumour-infiltrating lymphocytes (TILs) reflect antitumour immunity. Their evaluation of histopathology specimens is influenced by several factors and is subject to issues of reproducibility. ONEST (Observers Needed to Evaluate Subjective Tests) helps in determining the number of observers that would be sufficient for the reliable estimation of inter-observer agreement of TIL categorisation. This has not been explored previously in relation to TILs. ONEST analyses, using an open-source software developed by the first author, were performed on TIL quantification in breast cancers taken from two previous studies. These were one reproducibility study involving 49 breast cancers, 23 in the first circulation and 14 pathologists in the second circulation, and one study involving 100 cases and 9 pathologists. In addition to the estimates of the number of observers required, other factors influencing the results of ONEST were examined. The analyses reveal that between six and nine observers (range 2-11) are most commonly needed to give a robust estimate of reproducibility. In addition, the number and experience of observers, the distribution of values around or away from the extremes, and outliers in the classification also influence the results. Due to the simplicity and the potentially relevant information it may give, we propose ONEST to be a part of new reproducibility analyses.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers15041199</identifier><language>eng</language><publisher>MDPI AG</publisher><subject>Health aspects ; Lymphocytes</subject><ispartof>Cancers, 2023-02, Vol.15 (4)</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Cserni, Bálint</creatorcontrib><creatorcontrib>Kilma</creatorcontrib><creatorcontrib>O’Loughlin, Mark</creatorcontrib><creatorcontrib>Andreu, Xavier</creatorcontrib><creatorcontrib>Bagó-Horváth, Zsuzsanna</creatorcontrib><creatorcontrib>Bianchi, Simonetta</creatorcontrib><creatorcontrib>Chmielik, Ewa</creatorcontrib><creatorcontrib>Figueiredo, Paulo</creatorcontrib><creatorcontrib>Floris, Giuseppe</creatorcontrib><creatorcontrib>Foschini, Maria Pia</creatorcontrib><creatorcontrib>Kovács, Anikó</creatorcontrib><creatorcontrib>Heikkilä, Päivi</creatorcontrib><creatorcontrib>Kulka, Janina</creatorcontrib><creatorcontrib>Laenkholm, Anne-Vibeke</creatorcontrib><creatorcontrib>Liepniece-Karele, Inta</creatorcontrib><creatorcontrib>Marchiò, Caterina</creatorcontrib><creatorcontrib>Provenzano, Elena</creatorcontrib><creatorcontrib>Regitnig, Peter</creatorcontrib><creatorcontrib>Reiner, Angelika</creatorcontrib><creatorcontrib>Ryška, Aleš</creatorcontrib><creatorcontrib>Sapino, Anna</creatorcontrib><creatorcontrib>Stovgaard, Elisabeth Specht</creatorcontrib><creatorcontrib>Quinn, Cecily</creatorcontrib><creatorcontrib>Zolota, Vasiliki</creatorcontrib><creatorcontrib>Webber, Mark</creatorcontrib><creatorcontrib>Glynn, Sharon A</creatorcontrib><creatorcontrib>Bori, Rita</creatorcontrib><creatorcontrib>Csörgő, Erika</creatorcontrib><creatorcontrib>Oláh-Németh, Orsolya</creatorcontrib><creatorcontrib>Pancsa, Tamás</creatorcontrib><creatorcontrib>Sejben, Anita</creatorcontrib><creatorcontrib>Sejben, István</creatorcontrib><creatorcontrib>Vörös, András</creatorcontrib><creatorcontrib>Zombori, Tamás</creatorcontrib><creatorcontrib>Nyári, Tibor</creatorcontrib><creatorcontrib>Callagy, Grace</creatorcontrib><creatorcontrib>Cserni, Gábor</creatorcontrib><title>ONEST in Breast Cancer and Its Limitations</title><title>Cancers</title><description>Tumour-infiltrating lymphocytes (TILs) reflect the host's response against tumours. TILs have a strong prognostic effect in the so-called triple-negative (oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 negative) subset of breast cancers and predict a better response when primary systemic (neoadjuvant) treatment is administered. Although they are easy to assess, their quantitative assessment is subject to some inter-observer variation. ONEST (Observers Needed to Evaluate Subjective Tests) is a new way of analysing inter-observer variability and helps in estimating the number of observers required for a more reliable estimation of this phenomenon. This aspect of reproducibility for TILs has not been explored previously. Our analysis suggests that between six and nine pathologists can give a good approximation of inter-observer agreement in TIL assessments. Tumour-infiltrating lymphocytes (TILs) reflect antitumour immunity. Their evaluation of histopathology specimens is influenced by several factors and is subject to issues of reproducibility. ONEST (Observers Needed to Evaluate Subjective Tests) helps in determining the number of observers that would be sufficient for the reliable estimation of inter-observer agreement of TIL categorisation. This has not been explored previously in relation to TILs. ONEST analyses, using an open-source software developed by the first author, were performed on TIL quantification in breast cancers taken from two previous studies. These were one reproducibility study involving 49 breast cancers, 23 in the first circulation and 14 pathologists in the second circulation, and one study involving 100 cases and 9 pathologists. In addition to the estimates of the number of observers required, other factors influencing the results of ONEST were examined. The analyses reveal that between six and nine observers (range 2-11) are most commonly needed to give a robust estimate of reproducibility. In addition, the number and experience of observers, the distribution of values around or away from the extremes, and outliers in the classification also influence the results. Due to the simplicity and the potentially relevant information it may give, we propose ONEST to be a part of new reproducibility analyses.</description><subject>Health aspects</subject><subject>Lymphocytes</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptjr1rwzAQxUVpoCHN3FXQreBUZ31ZY2rSNGCaId7DSZaCSiyD5f-fmrZDht4N73G89-MIeQK24dywV4fJ-TGDZALAmDuyLJkuC6WMuL_xD2Sd8xebh3PQSi_Jy_Fzd2ppTPRt9JgnWv-QKKaOHqZMm9jHCac4pPxIFgGv2a__dEXa911bfxTNcX-ot01xUVoWEEAhgrVKOlZx4ytUPhjDmRO6kqa0HG0pFdiymp9FC6CM86FjUgkROr4iz7_YC179OaYwTCO6PmZ33mrBGTAOck5t_knN2_k-uiH5EOf7TeEbY3dSUw</recordid><startdate>20230201</startdate><enddate>20230201</enddate><creator>Cserni, Bálint</creator><creator>Kilma</creator><creator>O’Loughlin, Mark</creator><creator>Andreu, Xavier</creator><creator>Bagó-Horváth, Zsuzsanna</creator><creator>Bianchi, Simonetta</creator><creator>Chmielik, Ewa</creator><creator>Figueiredo, Paulo</creator><creator>Floris, Giuseppe</creator><creator>Foschini, Maria Pia</creator><creator>Kovács, Anikó</creator><creator>Heikkilä, Päivi</creator><creator>Kulka, Janina</creator><creator>Laenkholm, Anne-Vibeke</creator><creator>Liepniece-Karele, Inta</creator><creator>Marchiò, Caterina</creator><creator>Provenzano, Elena</creator><creator>Regitnig, Peter</creator><creator>Reiner, Angelika</creator><creator>Ryška, Aleš</creator><creator>Sapino, Anna</creator><creator>Stovgaard, Elisabeth Specht</creator><creator>Quinn, Cecily</creator><creator>Zolota, Vasiliki</creator><creator>Webber, Mark</creator><creator>Glynn, Sharon A</creator><creator>Bori, Rita</creator><creator>Csörgő, Erika</creator><creator>Oláh-Németh, Orsolya</creator><creator>Pancsa, Tamás</creator><creator>Sejben, Anita</creator><creator>Sejben, István</creator><creator>Vörös, András</creator><creator>Zombori, Tamás</creator><creator>Nyári, Tibor</creator><creator>Callagy, Grace</creator><creator>Cserni, Gábor</creator><general>MDPI AG</general><scope/></search><sort><creationdate>20230201</creationdate><title>ONEST in Breast Cancer and Its Limitations</title><author>Cserni, Bálint ; Kilma ; O’Loughlin, Mark ; Andreu, Xavier ; Bagó-Horváth, Zsuzsanna ; Bianchi, Simonetta ; Chmielik, Ewa ; Figueiredo, Paulo ; Floris, Giuseppe ; Foschini, Maria Pia ; Kovács, Anikó ; Heikkilä, Päivi ; Kulka, Janina ; Laenkholm, Anne-Vibeke ; Liepniece-Karele, Inta ; Marchiò, Caterina ; Provenzano, Elena ; Regitnig, Peter ; Reiner, Angelika ; Ryška, Aleš ; Sapino, Anna ; Stovgaard, Elisabeth Specht ; Quinn, Cecily ; Zolota, Vasiliki ; Webber, Mark ; Glynn, Sharon A ; Bori, Rita ; Csörgő, Erika ; Oláh-Németh, Orsolya ; Pancsa, Tamás ; Sejben, Anita ; Sejben, István ; Vörös, András ; Zombori, Tamás ; Nyári, Tibor ; Callagy, Grace ; Cserni, Gábor</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g675-1f16aa1bb65c0839e8a6ef9930c478592b3ab2561b28041ab1169cefd05644fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Health aspects</topic><topic>Lymphocytes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cserni, Bálint</creatorcontrib><creatorcontrib>Kilma</creatorcontrib><creatorcontrib>O’Loughlin, Mark</creatorcontrib><creatorcontrib>Andreu, Xavier</creatorcontrib><creatorcontrib>Bagó-Horváth, Zsuzsanna</creatorcontrib><creatorcontrib>Bianchi, Simonetta</creatorcontrib><creatorcontrib>Chmielik, Ewa</creatorcontrib><creatorcontrib>Figueiredo, Paulo</creatorcontrib><creatorcontrib>Floris, Giuseppe</creatorcontrib><creatorcontrib>Foschini, Maria Pia</creatorcontrib><creatorcontrib>Kovács, Anikó</creatorcontrib><creatorcontrib>Heikkilä, Päivi</creatorcontrib><creatorcontrib>Kulka, Janina</creatorcontrib><creatorcontrib>Laenkholm, Anne-Vibeke</creatorcontrib><creatorcontrib>Liepniece-Karele, Inta</creatorcontrib><creatorcontrib>Marchiò, Caterina</creatorcontrib><creatorcontrib>Provenzano, Elena</creatorcontrib><creatorcontrib>Regitnig, Peter</creatorcontrib><creatorcontrib>Reiner, Angelika</creatorcontrib><creatorcontrib>Ryška, Aleš</creatorcontrib><creatorcontrib>Sapino, Anna</creatorcontrib><creatorcontrib>Stovgaard, Elisabeth Specht</creatorcontrib><creatorcontrib>Quinn, Cecily</creatorcontrib><creatorcontrib>Zolota, Vasiliki</creatorcontrib><creatorcontrib>Webber, Mark</creatorcontrib><creatorcontrib>Glynn, Sharon A</creatorcontrib><creatorcontrib>Bori, Rita</creatorcontrib><creatorcontrib>Csörgő, Erika</creatorcontrib><creatorcontrib>Oláh-Németh, Orsolya</creatorcontrib><creatorcontrib>Pancsa, Tamás</creatorcontrib><creatorcontrib>Sejben, Anita</creatorcontrib><creatorcontrib>Sejben, István</creatorcontrib><creatorcontrib>Vörös, András</creatorcontrib><creatorcontrib>Zombori, Tamás</creatorcontrib><creatorcontrib>Nyári, Tibor</creatorcontrib><creatorcontrib>Callagy, Grace</creatorcontrib><creatorcontrib>Cserni, Gábor</creatorcontrib><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cserni, Bálint</au><au>Kilma</au><au>O’Loughlin, Mark</au><au>Andreu, Xavier</au><au>Bagó-Horváth, Zsuzsanna</au><au>Bianchi, Simonetta</au><au>Chmielik, Ewa</au><au>Figueiredo, Paulo</au><au>Floris, Giuseppe</au><au>Foschini, Maria Pia</au><au>Kovács, Anikó</au><au>Heikkilä, Päivi</au><au>Kulka, Janina</au><au>Laenkholm, Anne-Vibeke</au><au>Liepniece-Karele, Inta</au><au>Marchiò, Caterina</au><au>Provenzano, Elena</au><au>Regitnig, Peter</au><au>Reiner, Angelika</au><au>Ryška, Aleš</au><au>Sapino, Anna</au><au>Stovgaard, Elisabeth Specht</au><au>Quinn, Cecily</au><au>Zolota, Vasiliki</au><au>Webber, Mark</au><au>Glynn, Sharon A</au><au>Bori, Rita</au><au>Csörgő, Erika</au><au>Oláh-Németh, Orsolya</au><au>Pancsa, Tamás</au><au>Sejben, Anita</au><au>Sejben, István</au><au>Vörös, András</au><au>Zombori, Tamás</au><au>Nyári, Tibor</au><au>Callagy, Grace</au><au>Cserni, Gábor</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ONEST in Breast Cancer and Its Limitations</atitle><jtitle>Cancers</jtitle><date>2023-02-01</date><risdate>2023</risdate><volume>15</volume><issue>4</issue><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>Tumour-infiltrating lymphocytes (TILs) reflect the host's response against tumours. TILs have a strong prognostic effect in the so-called triple-negative (oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 negative) subset of breast cancers and predict a better response when primary systemic (neoadjuvant) treatment is administered. Although they are easy to assess, their quantitative assessment is subject to some inter-observer variation. ONEST (Observers Needed to Evaluate Subjective Tests) is a new way of analysing inter-observer variability and helps in estimating the number of observers required for a more reliable estimation of this phenomenon. This aspect of reproducibility for TILs has not been explored previously. Our analysis suggests that between six and nine pathologists can give a good approximation of inter-observer agreement in TIL assessments. Tumour-infiltrating lymphocytes (TILs) reflect antitumour immunity. Their evaluation of histopathology specimens is influenced by several factors and is subject to issues of reproducibility. ONEST (Observers Needed to Evaluate Subjective Tests) helps in determining the number of observers that would be sufficient for the reliable estimation of inter-observer agreement of TIL categorisation. This has not been explored previously in relation to TILs. ONEST analyses, using an open-source software developed by the first author, were performed on TIL quantification in breast cancers taken from two previous studies. These were one reproducibility study involving 49 breast cancers, 23 in the first circulation and 14 pathologists in the second circulation, and one study involving 100 cases and 9 pathologists. In addition to the estimates of the number of observers required, other factors influencing the results of ONEST were examined. The analyses reveal that between six and nine observers (range 2-11) are most commonly needed to give a robust estimate of reproducibility. In addition, the number and experience of observers, the distribution of values around or away from the extremes, and outliers in the classification also influence the results. Due to the simplicity and the potentially relevant information it may give, we propose ONEST to be a part of new reproducibility analyses.</abstract><pub>MDPI AG</pub><doi>10.3390/cancers15041199</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2072-6694 |
ispartof | Cancers, 2023-02, Vol.15 (4) |
issn | 2072-6694 2072-6694 |
language | eng |
recordid | cdi_gale_infotracmisc_A743010315 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; PubMed Central |
subjects | Health aspects Lymphocytes |
title | ONEST in Breast Cancer and Its Limitations |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T03%3A32%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ONEST%20in%20Breast%20Cancer%20and%20Its%20Limitations&rft.jtitle=Cancers&rft.au=Cserni,%20B%C3%A1lint&rft.date=2023-02-01&rft.volume=15&rft.issue=4&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers15041199&rft_dat=%3Cgale%3EA743010315%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A743010315&rfr_iscdi=true |